Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

CYP2D6 Polymorphism and Parkinson's disease susceptibility

Identifieur interne : 000C11 ( Istex/Curation ); précédent : 000C10; suivant : 000C12

CYP2D6 Polymorphism and Parkinson's disease susceptibility

Auteurs : Nada Sabbagh [France] ; Alexis Brice [France] ; Delphine Marez [France] ; Alexandra Dürr [France] ; Maryline Legrand [France] ; Jean-Marc Lo Guidice [France] ; Alain Destée [France] ; Yves Agid [France] ; Franck Broly [France]

Source :

RBID : ISTEX:BBE899DED04E834D1E12DB14F2922F18FD82FEC0

English descriptors

Abstract

Following the recent identification of multiple novel mutations and alleles of the cytochrome P450 CYP2D6 gene which cause decreased, increased, or absent enzyme activity, we re‐examined the controversial hypothesis of a role of the CYP2D6 polymorphism in Parkinson's disease (PD) susceptibility. For this purpose, a strategy based on PCR‐SSCP and RFLP analyses allowing the detection of all known CYP2D6 alleles was performed in DNA from 109 patients with sporadic PD. This strategy was also applied to DNA from 68 members of PD families including 18 affected and 50 unaffected members. Seventeen mutations occurring alone or in various combination on 14 alleles of CYP2D6 have been identified in patients with sporadic PD. Moreover, 12 mutations and nine alleles of the gene have been characterized in members of PD families. No significant difference was observed when the distribution of mutations and alleles of CYP2D6 was compared between the PD patients and 514 control subjects previously analyzed using the same strategy. There was also no difference in the distribution of phenotypes predicted from genotypes between both groups. In addition, when the distribution of CYP2D6 genotypes was compared, no difference between affected and unaffected members of PD families was observed. These data indicate that CYP2D6 polymorphism is not a susceptibility factor to PD.

Url:
DOI: 10.1002/1531-8257(199903)14:2<230::AID-MDS1005>3.0.CO;2-6

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:BBE899DED04E834D1E12DB14F2922F18FD82FEC0

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">CYP2D6 Polymorphism and Parkinson's disease susceptibility</title>
<author>
<name sortKey="Sabbagh, Nada" sort="Sabbagh, Nada" uniqKey="Sabbagh N" first="Nada" last="Sabbagh">Nada Sabbagh</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Marez, Delphine" sort="Marez, Delphine" uniqKey="Marez D" first="Delphine" last="Marez">Delphine Marez</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Legrand, Maryline" sort="Legrand, Maryline" uniqKey="Legrand M" first="Maryline" last="Legrand">Maryline Legrand</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lo Guidice, Jean Arc" sort="Lo Guidice, Jean Arc" uniqKey="Lo Guidice J" first="Jean-Marc" last="Lo Guidice">Jean-Marc Lo Guidice</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destée">Alain Destée</name>
<affiliation wicri:level="1">
<mods:affiliation>Service de Neurologie A, Centre Hospitalier Régional et Universitaire de Lille, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie A, Centre Hospitalier Régional et Universitaire de Lille, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Broly, Franck" sort="Broly, Franck" uniqKey="Broly F" first="Franck" last="Broly">Franck Broly</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BBE899DED04E834D1E12DB14F2922F18FD82FEC0</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1002/1531-8257(199903)14:2<230::AID-MDS1005>3.0.CO;2-6</idno>
<idno type="url">https://api.istex.fr/document/BBE899DED04E834D1E12DB14F2922F18FD82FEC0/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C11</idno>
<idno type="wicri:Area/Istex/Curation">000C11</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">CYP2D6 Polymorphism and Parkinson's disease susceptibility</title>
<author>
<name sortKey="Sabbagh, Nada" sort="Sabbagh, Nada" uniqKey="Sabbagh N" first="Nada" last="Sabbagh">Nada Sabbagh</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Marez, Delphine" sort="Marez, Delphine" uniqKey="Marez D" first="Delphine" last="Marez">Delphine Marez</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Legrand, Maryline" sort="Legrand, Maryline" uniqKey="Legrand M" first="Maryline" last="Legrand">Maryline Legrand</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lo Guidice, Jean Arc" sort="Lo Guidice, Jean Arc" uniqKey="Lo Guidice J" first="Jean-Marc" last="Lo Guidice">Jean-Marc Lo Guidice</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destée">Alain Destée</name>
<affiliation wicri:level="1">
<mods:affiliation>Service de Neurologie A, Centre Hospitalier Régional et Universitaire de Lille, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie A, Centre Hospitalier Régional et Universitaire de Lille, Lille</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale and Fédération de Neurologie, Hôpital de la Salpêtrière, Bd. de l'Hôpital, Paris</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Broly, Franck" sort="Broly, Franck" uniqKey="Broly F" first="Franck" last="Broly">Franck Broly</name>
<affiliation wicri:level="1">
<mods:affiliation>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Biochimie & Biologie Moléculaire de l'Hôpital Calmette, Lille</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="1999-03">1999-03</date>
<biblScope unit="vol">14</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="230">230</biblScope>
<biblScope unit="page" to="236">236</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BBE899DED04E834D1E12DB14F2922F18FD82FEC0</idno>
<idno type="DOI">10.1002/1531-8257(199903)14:2<230::AID-MDS1005>3.0.CO;2-6</idno>
<idno type="ArticleID">MDS1005</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>CYP2D6 polymorphism</term>
<term>Parkinson's disease</term>
<term>SSCP</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Following the recent identification of multiple novel mutations and alleles of the cytochrome P450 CYP2D6 gene which cause decreased, increased, or absent enzyme activity, we re‐examined the controversial hypothesis of a role of the CYP2D6 polymorphism in Parkinson's disease (PD) susceptibility. For this purpose, a strategy based on PCR‐SSCP and RFLP analyses allowing the detection of all known CYP2D6 alleles was performed in DNA from 109 patients with sporadic PD. This strategy was also applied to DNA from 68 members of PD families including 18 affected and 50 unaffected members. Seventeen mutations occurring alone or in various combination on 14 alleles of CYP2D6 have been identified in patients with sporadic PD. Moreover, 12 mutations and nine alleles of the gene have been characterized in members of PD families. No significant difference was observed when the distribution of mutations and alleles of CYP2D6 was compared between the PD patients and 514 control subjects previously analyzed using the same strategy. There was also no difference in the distribution of phenotypes predicted from genotypes between both groups. In addition, when the distribution of CYP2D6 genotypes was compared, no difference between affected and unaffected members of PD families was observed. These data indicate that CYP2D6 polymorphism is not a susceptibility factor to PD.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C11 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000C11 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:BBE899DED04E834D1E12DB14F2922F18FD82FEC0
   |texte=   CYP2D6 Polymorphism and Parkinson's disease susceptibility
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024